|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 9/20 |
| (11) | Patento numeris | 2217213 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 08844404.7 |
| Europos patento paraiškos padavimo data | 2008-10-29 | |
| (97) | Europos patento paraiškos paskelbimo data | 2010-08-18 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2017-05-24 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2008/081496 |
| Data | 2008-10-29 |
| (87) | Numeris | WO 2009/058798 |
| Data | 2009-05-07 |
| (30) | Numeris | Data | Šalis |
| 983973 P | 2007-10-31 | US |
| (72) |
BUNICK, Frank, US
LUBER, Joseph, US
|
| (73) |
Johnson & Johnson Consumer Inc.,
199 Grandview Road, Skillman, NJ 08558,
US
|
| (54) | ORALLY DISINTEGRATIVE DOSAGE FORM |
| ORALLY DISINTEGRATIVE DOSAGE FORM |